DeepMed Research

JOHNS HOPKINS UNIVERSITY

🇳🇦Namibia

Country: 🇳🇦Namibia

Ownership: -

Established: 1876-01-01

Employees: 19.4K

Market Cap: -

Website: https://www.jhu.edu/

Clinical Trials

An Innovative Intervention for OUD Treatment

Phase 2

Recruiting

Conditions: Opioid-Related Disorders
Opioid Dependence
Opioid Addiction
Opioid Withdrawal

Interventions: Drug: Lofexidine
Drug: Placebo
Device: Bridge Device
Device: Sham Bridge Device

First Posted Date: 2020-03-27

Last Posted Date: 2024-10-09

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 75

Registration Number: NCT04325659

Locations: 🇺🇸
Behavioral Pharmacology Research Unit, Baltimore, Maryland, United States

Convalescent Plasma to Stem Coronavirus (CSSC-001)

Phase 2

Completed

Conditions: Convalescence
Coronavirus

Interventions: Biological: Anti- SARS-CoV-2 Plasma
Biological: SARS-CoV-2 non-immune Plasma

First Posted Date: 2020-03-27

Last Posted Date: 2022-04-26

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 180

Registration Number: NCT04323800

Locations: 🇺🇸
University of Miami, Coral Gables, Florida, United States
🇺🇸
University of California, Los Angeles, Los Angeles, California, United States
🇺🇸
NorthShore University HealthSystem, Evanston, Illinois, United States

and more 22 locations

Passport to Freedom: Health and Housing

Not Applicable

Withdrawn

Conditions: Trauma

Interventions: Behavioral: Passport to Freedom (P2F)

First Posted Date: 2020-03-26

Last Posted Date: 2020-07-28

Lead Sponsor: Johns Hopkins University

Registration Number: NCT04322903

Non-organic Signs to Predict Outcomes for Neck Pain

Completed

Conditions: Cervical Radiculopathy
Cervical Radicular Pain

Interventions: Procedure: Cervical epidural steroid injection

First Posted Date: 2020-03-25

Last Posted Date: 2022-06-10

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 78

Registration Number: NCT04320836

Locations: 🇺🇸
Johns Hopkins, Baltimore, Maryland, United States
🇰🇷
Seoul National University, Seoul, Korea, Republic of
🇺🇸
DC VA Medical Center, Washington, District of Columbia, United States

Effects of Dietary Conditions on Drug Response

Phase 1

Terminated

Conditions: Healthy

Interventions: Drug: Blinded drug dose conditions

First Posted Date: 2020-03-20

Last Posted Date: 2024-08-09

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 1

Registration Number: NCT04315961

Locations: 🇺🇸
Behavioral Pharmacology Research Unit, Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States

Clinical Utility of Handheld Hydrogen Breathalyzer in Identification of Food Sensitivities (AIRE Study)

Not Applicable

Completed

Conditions: Small Bowel Bacterial Overgrowth Syndrome
SIBO

Interventions: Device: Hydrogen content recording

First Posted Date: 2020-03-16

Last Posted Date: 2025-05-28

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 45

Registration Number: NCT04309396

Locations: 🇺🇸
Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States

Augmented BLAdder NecK rEconstruction Trial for Improved Urinary Function After Radical Prostatectomy

Not Applicable

Terminated

Conditions: Urinary Incontinence
Prostate Cancer
Surgery

Interventions: Procedure: Augmented Bladder Neck Reconstruction
Procedure: Standard Bladder Neck Reconstruction

First Posted Date: 2020-03-12

Last Posted Date: 2021-03-17

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 31

Registration Number: NCT04305379

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States

Mindfulness Based Stress Reduction and Post-Stroke Cognition

Not Applicable

Completed

Conditions: Stroke
Cognitive Impairment
Stroke Sequelae
Depression

Interventions: Behavioral: Mindfulness Based Stress Reduction (MBSR)
Behavioral: Stroke Support Group (SSG)

First Posted Date: 2020-03-10

Last Posted Date: 2024-12-20

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 30

Registration Number: NCT04302493

Locations: 🇺🇸
Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States

Pioglitazone for Idiopathic Gastroparesis

Early Phase 1

Completed

Conditions: Gastroparesis

Interventions: Drug: Pioglitazone 30 mg

First Posted Date: 2020-03-09

Last Posted Date: 2025-04-30

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 14

Registration Number: NCT04300127

Locations: 🇺🇸
Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States

Association of Mood With Risk for Atherosclerosis

Completed

Conditions: Vascular Stiffness
Sleep
Elevated Blood Pressure
Mood Disorders
Overweight and Obesity
Hypertension

Interventions: Diagnostic Test: Cardiovascular Assessments
Diagnostic Test: Actigraphy
Diagnostic Test: Laboratory assessments
Behavioral: Emotional/ Behavioural assessments

First Posted Date: 2020-03-06

Last Posted Date: 2022-08-23

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 37

Registration Number: NCT04298944

Locations: 🇺🇸
Johns Hopkins School of Medicine Division of Pediatric Nephrology, Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy